KSPHF:OTCMKTS
Kissei Pharmaceutical Co Ltd
$24.50
0.00%
(0.00) 1D
Okt 1, 10:21:43 AM GMT-4 · USD
search
Lahat ng simbolo
| Simbolo | Presyo | Palitan | % ng Pagbabago |
|---|
insights_autoBumubuo ng mga nangungunang insight para sa KSPHF...
Mkt. cap
175.00B
Avg. na dami
20.00
Dami
0.00
Mataas nang 52-wk
$31.90
Mababa nang 52-wk
$24.50
Beta
13.94
Mga natitirang share
46.54M
Bilang ng mga empleyado
2K
Mkt. cap
175.00B
Avg. na dami
20.00
Dami
0.00
Mataas nang 52-wk
$31.90
Mababa nang 52-wk
$24.50
Beta
13.94
Mga natitirang share
46.54M
Bilang ng mga empleyado
2K
Mga balita at kwento
Mula sa mga source sa web at partner sa balita
ad-hoc-news.de
·
1 araw ang nakalipas
Kissei discloses cyberattack: what it means for Kissei stock
Profile
Kissei Pharmaceutical is a pharmaceutical company based in Matsumoto, Nagano, Japan. Products discovered or developed by Kissei include:
Difelikefalin
Fostamatinib
Linzagolix
Mitiglinide
Remogliflozin etabonate
Silodosin
Tranilast
In March 2020, Kissei and CG Oncology, Inc. announced an exclusive license, development, and commercialization agreement for CG's oncolytic immunotherapy drug CG0070. The agreement covered Japan, South Korea, Taiwan, and other Asian countries, but not China. Wikipedia
Tungkol sa Kissei Pharmaceutical Co Ltd
CEOMutsuo Kanzawa
Mga Empleyado1.79K
ItinatagAgo 9, 1946
HeadquartersMatsumoto, Prepektura ng Nagano, Japan
Sektor-
Websitekissei.co.jp